Catalent

Article

Sponsored Content

Catalent’s next-generation cell line development technology, GPEx® Boost, leverages GPEx platform improvements and a glutamine synthase knock-out CHO cell line, providing the same stability and proven technology of traditional GPEx technology with enhanced benefits, including increased titer for even the most difficult-to-express proteins, improved cell growth and viability, and fewer process steps, resulting in reduced timelines.

Catalent
14 Schoolhouse Road Somerset, NJ 08873 USA
Tel. +1.888.765.8846
solutions@catalent.com
www.catalent.com

Related Content
Catalent's Flexible Fill/Finish Capabilities for Drug Products

Catalent's Flexible Fill/Finish Capabilities for Drug Products CPHI Barcelona

BioPharm International Editors
October 10th 2023
Article

Catalent provides fill/finish services across a range of product formats from clinical to commercial scale.

GPEx® Lightning Cell Line Development Technology

GPEx® Lightning Cell Line Development Technology

Catalent
July 14th 2023
Article

Shorten clinical development timeline using novel GPEx® Lightning cell line development technology.

Immediate Availability of All Protein A Resins

Immediate Availability of All Protein A Resins

Purolite
July 14th 2023
Article

Accelerate your downstream purification with high yield, high recovery & fewer cycles and a faster route to market.

Site Logo

Introducing the BIOne 10L Single-Use Bioreactor

Distek, Inc
April 1st 2023
Article

The BIOne 10L SUB is highly innovative with expanded processing capabilities, ideal for scale-down modeling, material generation, and process optimization.

Catalent Cell & Gene Therapy

Catalent's UpTempo℠ AAV Platform

Catalent
March 17th 2023
Article

CDMO Catalent’s UpTempo℠ adeno-associated viral (AAV) platform process accelerates time from gene to clinic.

2023 PDA Annual Meeting

2023 PDA Annual Meeting

Parenteral Drug Association (PDA)
February 7th 2023
Article

The 2023 PDA Annual Meeting is heading to New Orleans, LA, April 3-5.

© 2024 MJH Life Sciences

All rights reserved.